All In MedTech

FDA Clearance Tracker · P200030-S014

GORE®1 EXCLUDER® Conformable AAA Endoprosthesis (CEXC), GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC)

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 19, 2026Latest source record: Apr 5, 2024 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Apr 5, 2024

Approved

Time to decision

178 days

Received Oct 10, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Panel Track

Device class

Class III

The decision

FDA number
P200030-S014
Device name
GORE®1 EXCLUDER® Conformable AAA Endoprosthesis (CEXC), GORE® EXCLUDER® Conformable AAA Endoprosthesis (EXCC)
Applicant location
Phonix, AZ
Received
Oct 10, 2023
Decided
Apr 5, 2024
Decision
Approved
Supplement type
Panel Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P200030

Device type

Device class
Class III

Every decision under product code MIH

FDA's approval statement

As written in FDA's record.

Approval for expanding the indications for use

Source documents

Other decisions for W. L. Gore and Associates, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

1 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.